Dogwood Therapeutics, Inc. SEC filings DWTX
Dogwood Therapeutics, Inc. has 329 filings in SEC EDGAR's recent list, going back to Jul 24, 2020. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| S-3 | Shelf registration | Oct 30, 2026 | — |
| 4 | Insider transaction | Oct 27, 2026 | Oct 26, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 27, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 21, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 19, 2026 | Oct 19, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| ARS | Annual report to shareholders | Apr 27, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 16, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 26, 2026 | Mar 26, 2026 |
| 10-K | Annual report | Mar 18, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Mar 12, 2026 | Mar 11, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 5, 2026 |
| DEF 14A | Proxy statement | Feb 13, 2026 | Mar 11, 2026 |
| EFFECT | Filing | Jan 29, 2026 | — |
| CORRESP | Letter to the SEC | Jan 27, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2026 | — |
| PRE 14A | Preliminary proxy statement | Jan 23, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 20, 2026 | Jan 20, 2026 |
| S-3 | Shelf registration | Jan 15, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure
|
Jan 13, 2026 | Jan 9, 2026 |
| 424B5 | Prospectus supplement | Jan 13, 2026 | — |
| S-8 | Employee stock plan registration | Jan 8, 2026 | — |
| 4 | Insider transaction | Dec 5, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Dec 5, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Dec 5, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Dec 5, 2025 | Dec 4, 2025 |
| 8-K |
Current report
Material agreement
|
Nov 28, 2025 | Nov 28, 2025 |
| 424B5 | Prospectus supplement | Nov 28, 2025 | — |
| 4 | Insider transaction | Nov 25, 2025 | Nov 21, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 25, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Nov 21, 2025 | Nov 21, 2025 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| DEF 14A | Proxy statement | Oct 20, 2025 | Nov 21, 2025 |
| S-3/A | Filing | Oct 16, 2025 | — |
| DEFA14A | Additional proxy material | Oct 9, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 9, 2025 | Oct 9, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 8, 2025 | Nov 21, 2025 |
| S-3 | Shelf registration | Oct 1, 2025 | — |
| DEFA14A | Additional proxy material | Sep 29, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 29, 2025 | Sep 29, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| S-8 | Employee stock plan registration | Jun 26, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 24, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| EFFECT | Filing | Jun 2, 2025 | — |
| CORRESP | Letter to the SEC | May 29, 2025 | — |
| UPLOAD | Letter from the SEC | May 28, 2025 | — |
| S-3 | Shelf registration | May 23, 2025 | — |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Other events
|
Apr 3, 2025 | Apr 3, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 3 | Initial insider ownership | Mar 20, 2025 | Mar 12, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 17, 2025 | — |
| 4 | Insider transaction | Mar 17, 2025 | Mar 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 17, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 17, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 14, 2025 | Mar 12, 2025 |
| 424B5 | Prospectus supplement | Mar 14, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 12, 2025 | Mar 12, 2025 |
| 8-K/A | Amended current report | Dec 18, 2024 | Oct 4, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 21, 2024 | Nov 15, 2024 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Other events
|
Oct 30, 2024 | Oct 29, 2024 |
| 3 | Initial insider ownership | Oct 17, 2024 | Oct 7, 2024 |
| 3 | Initial insider ownership | Oct 17, 2024 | Oct 7, 2024 |
| 3 | Initial insider ownership | Oct 17, 2024 | Oct 7, 2024 |
| SC 13D | Ownership over 5% (active) | Oct 15, 2024 | — |
| DEFA14A | Additional proxy material | Oct 7, 2024 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Oct 7, 2024 | Oct 4, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 12, 2024 | Jun 11, 2024 |
| 424B4 | Prospectus | May 20, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
May 20, 2024 | May 19, 2024 |
| 424B4 | Prospectus | May 17, 2024 | — |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Listing notice
|
May 7, 2024 | May 1, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 18, 2024 |
| 10-K/A | Amended annual report | Mar 8, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Mar 6, 2024 | Mar 1, 2024 |
| 10-K | Annual report | Mar 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| DEFA14A | Additional proxy material | Feb 27, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Feb 27, 2024 | Feb 26, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| DEF 14A | Proxy statement | Feb 2, 2024 | Mar 1, 2024 |
| PRE 14A | Preliminary proxy statement | Jan 22, 2024 | Mar 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 3, 2024 | Jan 3, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2023 | — |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 7, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Agreement ended
|
Sep 18, 2023 | Sep 18, 2023 |
| 4 | Insider transaction | Aug 22, 2023 | Aug 21, 2023 |
| 4 | Insider transaction | Aug 18, 2023 | Aug 17, 2023 |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Other events
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 17, 2023 | Jul 14, 2023 |
| 8-K |
Current report
Material agreement
|
Jul 14, 2023 | Jul 14, 2023 |
| 424B5 | Prospectus supplement | Jul 14, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 15, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Jun 13, 2023 | — |
| 8-K |
Current report
Other events
|
May 25, 2023 | May 24, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | May 15, 2023 | — |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Other events
|
May 2, 2023 | May 2, 2023 |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 27, 2023 | Jun 15, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 13, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 13, 2023 | Apr 13, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 31, 2023 | — |
| 10-K | Annual report | Mar 14, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2023 | Mar 14, 2023 |
| 4/A | Filing | Feb 15, 2023 | Dec 12, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Dec 21, 2022 | — |
| 4 | Insider transaction | Dec 14, 2022 | Dec 12, 2022 |
| 4 | Insider transaction | Dec 14, 2022 | Dec 12, 2022 |
| 4 | Insider transaction | Dec 14, 2022 | Dec 12, 2022 |
| 4 | Insider transaction | Dec 14, 2022 | Dec 12, 2022 |
| 4 | Insider transaction | Dec 12, 2022 | Dec 8, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 28, 2022 | Nov 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2022 | Nov 16, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Listing notice
|
Nov 2, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 27, 2022 | Sep 27, 2022 |
| SC 13G | Ownership over 5% (passive) | Sep 21, 2022 | — |
| 424B4 | Prospectus | Sep 21, 2022 | — |
| 8-K |
Current report
Material agreement, Other events
|
Sep 20, 2022 | Sep 19, 2022 |
| FWP | Free writing prospectus | Sep 19, 2022 | — |
| 424B4 | Prospectus | Sep 19, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 19, 2022 | Sep 19, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 4 | Insider transaction | Jun 30, 2022 | Jun 23, 2022 |
| 4 | Insider transaction | Jun 30, 2022 | Jun 23, 2022 |
| 4 | Insider transaction | Jun 30, 2022 | Jun 23, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DWTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Alpharetta, GA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1818844
- Former names
- Virios Therapeutics, Inc. (until Oct 15, 2024); Virios Therapeutics, LLC (until Dec 16, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.